+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 3 Actively Recruiting clinical trials

C

Actively Recruiting

Researchers are evaluating the safety and effectiveness of two antibiotic treatment strategies for adults hospitalized with suspected community-acquired sepsis. The study compares empirical combination therapy using gentamicin with narrow spectrum betalactams penicillin, ampicillin, or cloxacillin against empirical therapy with broad spectrum betalactams cefotaxime or piperacillin-tazobactam. The goal is to determine if the combination therapy is as safe as broad spectrum therapy, particularly regarding kidney injury and death, while also examining its impact on antibiotic resistance and the gut microbiome. Participants are randomly assigned to receive either gentamicin plus a narrow spectrum betalactam or one of the broad spectrum betalactams as empirical treatment for suspected sepsis. Treatments are given according to hospital protocols during the initial management of sepsis. The study is designed as a pragmatic clinical trial with parallel groups and does not use blinding. The investigation spans up to 30 days after randomization for primary outcomes, with follow-up during the hospital stay and after discharge. During the study, participants are monitored for various outcomes including 30-day mortality, acute kidney injury within 30 days, duration of hospital and intensive care stays, ventilator and vasopressor therapy use, hospital readmissions, and antibiotic treatment duration. Safety and treatment effects are assessed through clinical observations and data collected during hospitalization and up to 30 days after discharge. The total participation time covers the initial hospital treatment period and the 30-day follow-up after randomization.

Age: 18Years +All GendersPhase 4
15 locations
E

Actively Recruiting

Researchers are evaluating whether a preoperative genicular nerve block GNB can reduce pain and improve recovery after total knee arthroplasty TKA in adults with knee osteoarthritis OA. This study aims to find out if the nerve block reduces pain during movement 24 hours after surgery, decreases opioid use, and enhances physical activity and function. The trial is randomized and placebo-controlled to ensure unbiased comparison of outcomes. Participants will be randomly assigned to receive either an ultrasound-guided GNB using ropivacaine or a placebo saline injection before their knee replacement surgery. Both treatments target three genicular nerves around the knee with a total injection volume of 15 mL. All participants will undergo standard surgical and postoperative care regardless of their group. During the 3-month follow-up, participants will report their pain levels at various time points and complete questionnaires on function, quality of life, and recovery. They will also wear an activity monitor to track physical activity. Researchers will measure pain scores, opioid consumption, joint awareness, and step counts, while monitoring for side effects and assessing cost-effectiveness of the treatment.

Age: 18Years - 80YearsAll GendersPhase Not Applicable
1 location
I

Actively Recruiting

Researchers are investigating whether applying tranexamic acid TXA directly onto the surgical wound can influence the occurrence of complications after plastic surgery. The study focuses on complications such as re-bleeding needing intervention, wound infections, wound rupture, seroma formation, or blood clots. This is a phase 4 prevention trial involving patients undergoing plastic surgery procedures where TXA might be used to reduce bleeding. Participants will receive a single local application of the study drug at the end of surgery. The study drug is provided in identical ampoules containing either tranexamic acid or a saline placebo, and neither the participants nor the study staff will know which they receive. The drug will be diluted and applied according to standard surgical practices. The trial compares the effects of TXA versus placebo on postoperative complications. During the 30 days following surgery, researchers will collect data on any serious complications through medical record review, electronic self-report forms sent to patients, and follow-up phone calls. The primary outcome is postoperative re-bleeding within 10 days, with secondary outcomes including infections, wound rupture, seroma, thromboembolic events, and other adverse effects within 30 days. Safety and scientific integrity are overseen by an independent data monitoring committee, and all information is stored securely in a web-based system.

Age: 18Years +All GendersPhase 4
11 locations